JOHNSON & JOHNSON

Add to a listPDF Report

Johnson & Johnson

Equities

JNJ

US4781601046

Pharmaceuticals

Real-time Estimate Cboe BZX 00:15:49 2026-02-23 pm EST			5-day change	1st Jan Change
246.07 USD	+1.48%		+1.11%	+18.88%

1h	Bayer sues Johnson & Johnson over marketing of prostate cancer drug	RE
1h	Johnson & Johnson Sued by Bayer Over Alleged False Claims on NUBEQA	MT

Summary

Quotes

Charts

News

Company

Financials

Valuation

Consensus

Ratings

Calendar

Sector

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Johnson & Johnson Sued by Bayer Over Alleged False Claims on NUBEQA

Share

MT Newswires - 2026

Share

Latest news about Johnson & Johnson

...

1h	Bayer sues Johnson & Johnson over marketing of prostate cancer drug	RE
1h	Johnson & Johnson Sued by Bayer Over Alleged False Claims on NUBEQA	MT
1h	Johnson & Johnson Sued by Bayer for Alleged False Claims on NUBEQA	MT
1h	Johnson & Johnson Sued by Bayer Over Alleged False Claims Regarding Nubeqa's Efficacy	MT
1h	EU Commission OKs New Dosing Options for J&J's Non-small Lung Cancer Treatment	MT
1h	Bayer files lawsuit against Johnson & Johnson, Janssen Biotech	RE
4h	Blackstone, J&J in Co-Funding Pact for Acute Myeloid Leukemia Drug	DJ

Read Full Story: https://news.google.com/rss/articles/CBMiugFBVV95cUxNWXk0NnRXQ0VabFN5VUIwc1p3...